The role of the pharmaceutical industry is to deliver therapeutic innovations and bring them to real-life medical practices. Customer engagement is one of the critical component of the pharma model to enable to transfer these innovations into care practices and bring efficient and safe treatment options to patients to improve their lives. With this paper we aim to help decision makers within pharma companies reach this goal and excel in its execution while adapting it to today’s digitalized world, made even more online-driven by the covid-19 pandemic.
Cancer will soon be death cause number 1 on a global level representing strong unmet medical needs and enormous costs for healthcare systems. New, innovative treatments and technologies as well as personalization of treatments are required in order to drastically improve the patients’ situation and cure cancer one day.
From large industrial players to specialized SMEs, several tens of billions of euros will very soon be committed, each year in Europe, to the development of the hydrogen sector, so that it can take its place alongside batteries and biofuels.
The field of neuroscience has been the stage of enormous scientific and technological progress with significant investments from both public and private actors provided to increase our understanding of the functioning of human brain in physiological and pathological conditions.